{{Rsnum
|rsid=1004984
|Gene=CYP19A1
|Chromosome=15
|position=51321332
|Orientation=minus
|GMAF=0.4008
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|summary=may be associated with obesity-related phenotypes in Chinese women
|Gene_s=CYP19A1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 30.3 | 52.3 | 17.4
| HCB | 46.7 | 44.4 | 8.9
| JPT | 41.7 | 50.0 | 8.3
| YRI | 25.4 | 44.4 | 30.2
| ASW | 31.6 | 50.9 | 17.5
| CHB | 46.7 | 44.4 | 8.9
| CHD | 51.9 | 38.7 | 9.4
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 21.8 | 60.0 | 18.2
| MKK | 15.1 | 51.3 | 33.6
| TSI | 33.0 | 48.0 | 19.0
| HapMapRevision=28
}}[[CYP19A1]] genetic polymorphisms may be associated with [[obesity]] related phenotypes in Chinese women.{{PMID|16894362}}

{{PMID Auto
|PMID=18199708
|Title=Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.
|OA=1
}}

{{PMID Auto
|PMID=18622258
|Title=Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.
|OA=1
}}

{{PMID Auto
|PMID=18941913
|Title=Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.
|OA=1
}}

{{PMID Auto
|PMID=19015200
|Title=Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer.
|OA=1
}}

{{PMID Auto
|PMID=19555469
|Title=A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}